Home > Europol–EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone).

European Monitoring Centre for Drugs and Drug Addiction & EUROPOL. (2010) Europol–EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

[img]
Preview
PDF (Europol EMCDDA Mephadrone report) - Published Version
240kB
[img]
Preview
PDF (Europol EMCDDA Mephadrone report. Annex 1 Main information sources) - Supplemental Material
186kB
[img]
Preview
PDF (Europol EMCDDA Mephadrone report. Annex 2 images) - Supplemental Material
2MB
[img]
Preview
PDF (Europol EMCDDA Mephadrone report. Annex 3 online shops) - Supplemental Material
176kB

Europe has responded to rising concern over the use of the synthetic drug mephedrone by formally requesting a scientific investigation into the health and social risks of the substance. The decision was communicated to the EU drugs agency (EMCDDA) by the Council of the EU , in line with a legal procedure designed to respond to potentially threatening new psychoactive drugs in the EU.


Date:27 May 2010
Pages:22 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction & EUROPOL
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction & EUROPOL
Place of Publication:Lisbon
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > CNS stimulants
L Social psychology and related concepts > Legal availability or accessibility
B Substances > CNS stimulants > Synthetic cathinones > Mephedrone
B Substances > New (novel) psychoactive substances
VA Geographic area > Europe
A Substance use, abuse, and dependence > Effects and consequences

Repository Staff Only: item control page